Learn More
Medchemexpress LLC Ruboxistaurin mesylate | 192050-59-2 | MFCD09970504 | 99.9% | 564.65 | C29H32N4O6S | 5 MG

Supplier: Medchemexpress LLC HY10195A5MG
Ruboxistaurin mesylate is an orally active, ATP-competitive, and selective protein kinase C beta (PKCβ) inhibitor used in preclinical research on diabetic complications, retinal/eye disorders, and cardiovascular disease. It is supplied as a solid with high reported purity and is soluble in DMSO for in vitro applications.
- Selective PKCβ inhibitor with low-nanomolar potency.
- Orally active small molecule suitable for in vitro and in vivo studies.
- High reported purity (~99.9%) for research applications.
- Solid form, orange to red color, easy handling and storage.
- Soluble in DMSO at 50 MG/ML (88.55 mM); ultrasonic assistance may be required.
- Storage guidance: 4°C sealed; in solvent: -80°C (6 months), -20°C (1 month).
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.